Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eliem Therapeutics, Inc - Common Stock
(NQ:
ELYM
)
5.110
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eliem Therapeutics, Inc - Common Stock
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
October 02, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
September 11, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces Additions to its Leadership Team
August 26, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Second Quarter Financial Results
August 14, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
June 28, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
June 27, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
April 11, 2024
From
Halper Sadeh LLC
Via
Business Wire
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
April 11, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
July 20, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
May 11, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
March 06, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
February 09, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
November 30, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
November 14, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
November 08, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Provides Update on Pipeline Progress
October 05, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
